NEOG-100
Phase 1- Indications
- Advanced breast cancer, Non-small cell lung cancer
Company intelligence / Profile preview
Neogen operates globally with a broad commercial portfolio. Its products are widely used by food producers, laboratories, veterinarians, and researchers to ensure food safety and animal health. The company’s genomics labs are among the largest worldwide. No clinical trial results as it does not develop therapeutics but rather commercial diagnostic tools.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neogen Corporation.